Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology
Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test
Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma
Laurion 2026 Strategic Update For Ishkoday: Proposed Dual-Drill Program, Stockpile Gold Recovery Initiative, And Phased Path To Mineral Resource Estimate
Copper Quest Expands its Kitimat Copper Gold Project on the Strength of the AI Generated Porphyry Target
